Dr. Patrick Johnston Mille, MD

Dr. Mille practices at Jefferson University Physicians in Philadelphia, Pennsylvania.

Dr. Mille's NPI, 1346561230, was assigned on June 15, 2010. Dr. Mille graduated from Medical University of South Carolina College of Medicine in 2010. Dr. Mille holds Pennsylvania license MD448745.

Dr. Mille's primary practice is Jefferson University Physicians, at 1300 Wolf St, Philadelphia, PA 19148 in Philadelphia County. The practice phone is (215) 955-0000.

Dr. Mille's primary practice is Jefferson University Physicians in Philadelphia, Pennsylvania. Dr. Mille is also affiliated with Thomas Jefferson University Hospital. The medical group on file is Jefferson University Physicians. Dmand AI also links Dr. Mille to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mille practices, 4 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Mille's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Mille is licensed in Pennsylvania.

CMS data shows 527 Medicare services from Dr. Mille across 5 procedure codes in 2024, for 175 Medicare patients. Medicare paid $46,836 for them.

CMS counts 175 Medicare patients who saw Dr. Mille in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mille's median patient age at 71, with 31% women.

In 2024, Dr. Mille wrote 780 Medicare Part D claims for 134 patients. 65% of them were for generic drugs. CMS names the drug for 607 of them, across 18 drugs with 11 or more claims each, at $3,017,556 in total drug cost. In 2023, CMS named 472 claims across 17 drugs.

Dr. Mille accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mille as offering telehealth.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Mille, published from 2016 to 2024. The most frequent topics are Prostatic Neoplasms, Genetic Counseling and Genetic Testing. Dr. Mille has published most often in JCO Precis Oncol. Dr. Mille's most frequent co-authors are Leonard G. Gomella, MD, William J. Tester, MD and Edouard J. Trabulsi, MD.

Dmand AI links Dr. Mille to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Lymphatic Metastasis and Carcinoma, Renal Cell.

CMS Open Payments shows 6 general payments to Dr. Mille from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Galvanize Therapeutics, Inc paid the most, $172.

Dr. Mille graduated from Medical University of South Carolina College of Medicine in 2010.